Zydus Lifesciences has received final USFDA approval for its generic Ascorbic Acid Injection, used to treat scurvy. The approval covers the drug in two strengths,...
Zydus Lifesciences jumps to Rs 1,125 on 29 June, up 2%, after extending its Sterling Biotech API acquisition deadline to 30 September 2026. Active Pharmaceutical...
Shares of Zydus Lifesciences Ltd. are trading flat after reaching a dayβs high of Rs 1,125 on 17th September, following the boardβs approval of the...
The domestic equity indices ended the last trading on a high. BSE Sensex ended 418 points higher, while Nifty gained 114 points. Today, both indices...
Ahmedabad-headquartered pharmaceutical company Zydus Lifesciences announced on Tuesday that it has received approval for manufacturing and marketing a generic version of Varenicline tablets from the...